Follow
Pau Giner Bayarri
Pau Giner Bayarri
Médico Especialista en Neurofisiología Clínica
Verified email at gva.es
Title
Cited by
Cited by
Year
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study
V Villanueva, M Garcés, FJ López-González, X Rodriguez-Osorio, ...
Epilepsy research 126, 201-210, 2016
1202016
Perampanel in routine clinical use in idiopathic generalized epilepsy: the 12‐month GENERAL study
V Villanueva, J Montoya, A Castillo, JÁ Mauri‐Llerda, P Giner, ...
Epilepsia 59 (9), 1740-1752, 2018
1012018
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study
V Villanueva, JM Serratosa, E Guillamón, M Garcés, BG Giráldez, ...
Epilepsy research 108 (7), 1243-1252, 2014
742014
Drug-induced sleep endoscopy: a two drug comparison and simultaneous polysomnography
M Carrasco Llatas, G Agostini Porras, MT Cuesta González, ...
European Archives of Oto-Rhino-Laryngology 271, 181-187, 2014
612014
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs
E Santamarina, V Bertol, V Garayoa, MJ García-Gomara, ...
Seizure 83, 48-56, 2020
462020
Early add-on lacosamide in a real-life setting: results of the REALLY study
V Villanueva, M Garcés, E López-Gomáriz, JM Serratosa, ...
Clinical drug investigation 35, 121-131, 2015
372015
Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study
M Garcés, V Villanueva, JA Mauri, A Suller, C García, FJL González, ...
Epilepsy & Behavior 36, 144-152, 2014
352014
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic‐clonic seizures: experience from a national multicenter registry
R Toledano Delgado, I García‐Morales, B Parejo‐Carbonell, ...
Epilepsia 61 (6), 1109-1119, 2020
292020
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: experience from a multicenter, observational study
R Toledano, CE Jovel, A Jiménez-Huete, PG Bayarri, D Campos, ...
Epilepsy & Behavior 73, 173-179, 2017
212017
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: case series
A Gómez-Ibáñez, JM Serratosa, E Guillamón, M Garcés, BG Giráldez, ...
Seizure 48, 53-56, 2017
142017
EARLY‐ESLI study: Long‐term experience with eslicarbazepine acetate after first monotherapy failure
V Villanueva, P Bermejo, J Montoya, M Toledo, A Gómez‐Ibáñez, ...
Acta Neurologica Scandinavica 136 (3), 254-264, 2017
132017
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy
V Villanueva, P Bermejo, J Montoya, A Massot-Tarrús, ML Galiano, ...
Epilepsy & Behavior 97, 51-59, 2019
92019
Refractory nonconvulsive status epilepticus
N Torres-Cano, BP Giner, MR Chilet-Chilet, L Ruiz-Marquez, ...
Revista de neurologia 53 (4), 255, 2011
8*2011
El valencià, una llengua del segle XXI
P Giner Bayarri
València: Els Fanals de la Terra, 1999
8*1999
Utilidad de las pruebas neurofisiológicas como apoyo al test DSM-IV en el diagnóstico de TDAH. Av Neurol [Internet]. 2011; 2: 8
P Giner Bayarri, L Ruiz Márquez, A Rodrigo Sanbartolomé
5
Recomendaciones para la realización de potenciales evocados
PG Bayarri, MRC Chilet
Sociedad Española de Neurofisiología Clínica, 2022
42022
Neurofeedback versus pharmacological intervention in the treatment of childhood attention deficit/hyperactivity Disorder (ADHD): First spanish clinical neuropsychological study
D Medici, PG Bayarri, RC Chilet, JM Ibánez, MM Suarez-Varela, D Calvo
American Journal of Applied Psychology 7 (5), 57, 2018
42018
DISE: a 2-drug comparison and simultaneous polysomnography
M Carrasco, G Agostini, A Rodrigo, P Giner, F Gómez, J Dalmau
Otolaryngology—Head and Neck Surgery 147 (2_suppl), P120-P120, 2012
42012
Recomendaciones para el empleo de técnicas neurofisiológicas en el diagnóstico de muerte encefálica de la Sociedad de Neurofisiología Clínica de las Comunidades de Valencia y …
AV Arciniegas-Villanueva, E González-García, F Ordoño-Domínguez, ...
Revista de neurologia 75 (Supl 3), S1, 2022
32022
Evolution of safety profile of different therapeutic alternatives in restless legs syndrome (rls)
N Cano, P Bayarri, R Chilet, G Plaza, A Carrasco, J Ibanez
Sleep Med S 14, e88, 2013
32013
The system can't perform the operation now. Try again later.
Articles 1–20